NCT05361668 2026-03-19Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid SyndromeCrinetics Pharmaceuticals Inc.Phase 2 Completed36 enrolled 19 charts
NCT02826928 2026-01-21Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine TumorsCHU de ReimsPhase NA Completed116 enrolled